TV News LIES

Thursday, Dec 08th

Last update05:20:13 AM GMT

You are here News Health Study outcome won't sway company on eye drug

Study outcome won't sway company on eye drug

E-mail Print PDF

What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?

In the case of Genentech Inc., nothing.

The company declined to seek federal approval for the cheaper drug, Avastin, to treat the wet form of age-related macular degeneration. Nor would it help finance _ or cooperate with _ a National Eye Institute study comparing the effectiveness and safety of Avastin, a cancer drug, and the more expensive eye drug, Lucentis.

More...


Most Recent Related Stories...


Donald Trump Picks Fossil Fuel-Friendly Oklahoma Attorney General To Head EPA

Scott PruittPresident-elect Donald Trump has picked Oklahoma Attorney General Scott Pruitt to serve as the head of...

Ikea Is Giving Its Employees Up To Four Months Of Paid Parental Leave

Ikea to give four months paid parental leaveThe furniture giant Ikea is rolling out a paid parental leave plan that’s likely to be...

Ohio 'heartbeat bill' abortion ban moves to governor

Ohio 'heartbeat' abortion billOhio would have the country's most restrictive abortion laws under a bill sent to Gov. John...

VA may have infected 600 veterans with HIV and Hepatitis

Vets infected at VANearly 600 veterans could have been infected with HIV, Hepatitis B or Hepatitis C at a...
 
America's # 1 Enemy
Tee Shirt
& Help Support TvNewsLIES.org!
TVNL Tee Shirt
 
TVNL TOTE BAG
Conserve our Planet
& Help Support TvNewsLIES.org!
 
Get your 9/11 & Media
Deception Dollars
& Help Support TvNewsLIES.org!
 
The Loaded Deck
The First & the Best!
The Media & Bush Admin Exposed!